Detalhe da pesquisa
1.
Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction Treatment.
Clin Gastroenterol Hepatol
; 21(9): 2347-2358.e6, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36464141
2.
Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study.
Hepatology
; 71(2): 456-462, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31254392
3.
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV.
J Hepatol
; 2017 Sep 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28882581
4.
Response to Taiwan is on track of accelerating hepatitis C elimination by 2025.
Liver Int
; 40(6): 1507, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32329552
5.
Efficacy and safety of upadacitinib for 16-week extended induction and 52-week maintenance therapy in patients with moderately to severely active ulcerative colitis.
Aliment Pharmacol Ther
; 59(3): 393-408, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38010661
6.
Corrigendum to "Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV" [J Hepatol 68 (2018) 33-41].
J Hepatol
; 68(4): 867, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29366584
7.
Outcomes Following Adalimumab Bio-originator to Biosimilar Switch-A Comparison Using Real-world Patient- and Physician-Reported Data in European Countries.
Rheumatol Ther
; 10(2): 433-445, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36631636
8.
Content Validity and Psychometric Evaluation of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) in Patients with Crohn's Disease and Ulcerative Colitis.
Pharmacoecon Open
; 7(5): 823-840, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37296268
9.
Timing of elimination of hepatitis C virus in Canada's provinces.
Can Liver J
; 5(4): 493-506, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-38144411
10.
Cost-Effectiveness Analysis of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin Regimen for Patients Infected With Chronic Hepatitis C Virus Genotype 1 in Malaysia.
Value Health Reg Issues
; 21: 164-171, 2020 May.
Artigo
Inglês
| MEDLINE | ID: mdl-31978690
11.
A Cost-Effectiveness Analysis of Glecaprevir/Pibrentasvir Versus Existing Direct-Acting Antivirals to Treat Chronic Hepatitis C in Japan.
Adv Ther
; 37(1): 457-476, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31808054
12.
A tool to measure the impact of inaction toward elimination of hepatitis C: A case study in Korea.
PLoS One
; 15(4): e0232186, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32343727
13.
Newly Diagnosed Hepatitis C in the US Commercially Insured Population Before and After the 2012 Implementation of Expanded Screening Guidelines.
Am Health Drug Benefits
; 11(1): 30-37, 2018 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-29692878
14.
Prevalence and economic burden of extrahepatic manifestations of hepatitis C virus are underestimated but can be improved with therapy.
Hepatol Commun
; 1(5): 439-452, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29404471
15.
Geographic Variation in the Quality and Cost of Care for Patients with Rheumatoid Arthritis.
J Manag Care Spec Pharm
; 22(12): 1472-1481, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27882832
16.
Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States.
Adv Ther
; 33(8): 1316-30, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27342742
17.
The wider public health value of HCV treatment accrued by liver transplant recipients.
Am J Manag Care
; 22(6 Spec No.): SP212-9, 2016 May.
Artigo
Inglês
| MEDLINE | ID: mdl-27266951
18.
Value of expanding HCV screening and treatment policies in the United States.
Am J Manag Care
; 22(6 Spec No.): SP227-35, 2016 May.
Artigo
Inglês
| MEDLINE | ID: mdl-27266953
19.
Costs and spillover effects of private insurers' coverage of hepatitis C treatment.
Am J Manag Care
; 22(6 Spec No.): SP236-44, 2016 May.
Artigo
Inglês
| MEDLINE | ID: mdl-27266954